Skip to content
Technology
PIpeline
Menu Toggle
Intranasal Naloxone
Intranasal Epinephrine
About us
Contact
News
Investors
Menu Toggle
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Main Menu
Technology
PIpeline
Menu Toggle
Intranasal Naloxone
Intranasal Epinephrine
About us
Contact
News
Investors
Menu Toggle
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Nasus Pharma presented clinical results of intranasal epinephrine in EAACI
July 1, 2022
– July 3, 2022
European Academy of Allergy & Clinical Immunology (EAACI), July 1-3 2022, Prague
Download Presentation
View ALL Events
Scroll to Top